Poietis

France
Pessac, Nouvelle-Aquitaine, France, 33600

Company profile

Poietis company profile

Poietis is a biotechnology company specializing in the design of regenerative medicine therapies thanks to 4D laser bioprinting. It provides industrial stakeholders and researchers with a unique platform to design and manufacture bio-printed products for regenerative medicine, preclinical research and evaluating the efficacy of cosmetic products and ingredients. Poietis is currently developing 3D physiological models and has partnerships with major pharmaceutical and cosmetic groups. These tissue models allow for a more predictive in vitro assessment of the toxicity and the efficacy of candidate drugs and new cosmetic ingredients. Poietis has undertaken several projects with international leaders to develop complex bio-printed products such as the bioprinting of a hair follicle with L'Oréal (see Press Release). Poietis has developed its single-cell bioprinting platform to make tissue bioprinting processes compatible with the requirements of industrial production and the standards for manufacturing clinical products.

Business identity

Contact email
[email protected]
Phone number
+33 5 35 54 47 28
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2014-01-01, Year

Headquarters

Postal code
33600
Country code
FR
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$8.9M
Last funding
Series A / $6.2M / 2018-03-27
Last equity funding
Series A / $6.2M
Investors
2
Lead investors
1
Founders
2
Articles
12

Founders and investors

Founders

Bruno BrissonFabien Guillemot

Lead investors

WiSEED

Investors

Cédric DelormeWiSEED